Patient P-01445

Synthetic patientNBL-101 · Day 115 · 65–74 · F · baseline S13Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

45%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S13

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+18
Toxicity+11
Inflammatory activity+10
Nutritional resilience-8

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

30.3/100

worsening · +3.3 vs previous 14 d

Toxicity

Blood

31.1/100

improving · -1.5 vs previous 14 d

Sleep quality

Wearable

47.9/100

stable · -1.6 vs previous 14 d

Energy level

Daily log

5.4/10

stable · -0.1 vs previous 14 d

Stress level

Daily log

3.8/10

improving · -0.2 vs previous 14 d

Steps

Wearable

11,208

stable · +239 vs previous 14 d

Adherence

Companion

92.3 %

stable · +3.5 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 61 from the failing basin, 27 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep alcohol low
GI +3.5 next day on high-intake days · n 15

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+3.5detractor · 84%
Dietary fat load
-1.9no signal · 39%
Spicy / capsaicin
-1.6no signal · 26%
Simple carbohydrates
-0.8no signal · 17%
Histamine load
+0.6no signal · 15%
Insoluble fibre
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 73/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 63 ms
Sleep: 6.0 h
Steps: 9,442
Resting HR: 69 bpm

Daily log: GI score 30, nutritional resilience 58, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01804	38%	S19	AD-05	improved	61
P-01377	35%	S11	AD-05	no change	42
P-01541	34%	S09	AD-05	no change	43
P-01483	32%	S14	AD-05	no change	35
P-01679	32%	S12	AD-05	no change	39
P-01689	38%	S13	BR-03	no change	50
P-01350	31%	S19	BR-03	no change	34
P-01468	30%	S06	BR-03	no change	41
P-01313	29%	S01	BR-03	improved	32
P-01329	29%	S08	BR-03	improved	79
P-01450	28%	S09	BR-03	no change	36
P-01430	40%	S05	CR-01	improved	54